関連する実験動画
Updated: Sep 9, 2025

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.5K
CRISPR/dCas9-TET1による表遺伝子編集により,乳がん細胞におけるmiR-200cが再活性化される
Mahyar Zahraei1,2, Yasamin Azimi1, Morteza Karimipour1
1Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran, Islamic Republic of.
Scientific reports
|August 28, 2025
まとめ
CRISPRベースのエピジェネティック・エディティングにより 乳がん細胞の腫瘍抑制剤miR-200cが再活性化されました これは遺伝子発現を回復し 細胞の攻撃性を減らし 標的を絞った癌治療の 可能性を示しています
科学分野:
- エピジェネティクス
- 分子生物学
- 癌 研究
背景:
- miR-200cのような腫瘍抑制ミクロRNAのエピジェネティックサイレンシングは,がんの進行において一般的です.
- miR- 200cは,上皮からメゼンキマへの移行 (EMT) と転移の調節に不可欠です.
- DNAメチル化変化は逆転可能で 治療対象となります
研究 の 目的:
- CRISPR/dCas9-TET1がmiR-200cプロモーターをエピジェネティックに編集する可能性を調査する.
- 乳がん細胞系 (MCF- 7とMDA- MB- 231) の miR- 200c発現を回復する.
- EMTに関連する遺伝子発現と腫瘍細胞の攻撃性に対する miR - 200c 回復の影響を評価する.
主な方法:
- CRISPR/dCas9-TET1システムを活用して,miR-200cプロモーターのCpG豊富な領域を標的とした.
- サイト固有の脱メチル化のための2つのガイドRNA (gRNA) を設計し,配達した.
- 評価されたmiR- 200c発現,EMTマーカー (ZEB1,ZEB2,E- カデリン),KRAS,細胞活性,アポトーシス.
主要な成果:
- 両方のgRNAの併用により,miR- 200cの発現が相乗的に増加した.
- miR- 200cの上昇は,ZEB1,ZEB2,KRASの低下と,MDA- MB-231細胞におけるE- カデリンの増加につながった.
- 回復したmiR- 200cは抗腫瘍効果を示し,細胞活性を低下させ,アポトーシスを増加させた.
結論:
- CRISPR/dCas9-TET1による表遺伝子編集は miR-200cを効果的に再活性化します
- このアプローチはEMTに関連した遺伝子発現を逆転させ,乳がん細胞の攻撃性を減少させます.
- この発見は,乳がんの潜在的標的治療戦略としてCRISPR/dCas9-TET1を支持する.
関連する概念動画
CRISPR/Cas9 Genome Editing
211
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
211
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
Homologous Recombination
51.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
51.5K
CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K

